Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | - | 5.0 |
Min SIP Amount | ₹100 | ₹100 |
Expense Ratio | 2.24 | 1.68 |
NAV | ₹15.18 | ₹206.36 |
Fund Started | 12 Jul 2022 | 20 Aug 2004 |
Fund Size | ₹896.98 Cr | ₹15687.54 Cr |
Exit Load | Exit load of 1%, if redeemed within 90 days. | Exit load of 1% if redeemed within 1 year |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | 11.81% | 16.31% |
3 Year | - | 21.74% |
5 Year | - | 22.07% |
1 Year
3 Year
5 Year
Equity | 96.64% | 83.94% |
Cash | -0.13% | 15.74% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
---|---|
HDFC Bank Ltd. | 7.55% |
ICICI Bank Ltd. | 7.35% |
Infosys Ltd. | 6.07% |
Larsen & Toubro Ltd. | 5.93% |
Persistent Systems Ltd. | 5.10% |
Titan Company Ltd. | 5.02% |
Reliance Industries Ltd. | 4.44% |
Sun Pharmaceutical Industries Ltd. | 4.37% |
Marico Ltd. | 3.88% |
Kei Industries Ltd. | 3.64% |
Name | Assets |
---|---|
ICICI Bank Ltd. | 9.18% |
HDFC Bank Ltd. | 8.88% |
Axis Bank Ltd. | 8.49% |
Maruti Suzuki India Ltd. | 4.90% |
SBI Life Insurance Company Ltd. | 4.26% |
Kotak Mahindra Bank Ltd. | 4.24% |
Cipla Ltd. | 3.96% |
Bharti Airtel Ltd. | 3.63% |
HCL Technologies Ltd. | 3.41% |
Piramal Pharma Ltd. | 3.12% |
Name | Trideep Bhattacharya | Dhruv Muchhal |
Start Date | 01 Oct 2021 | 14 Sep 2023 |
Name
Start Date
Description | The scheme seeks to generate long term capital appreciation by investing in equity and equity related instruments of upto 30 companies across market capitalisation. | The scheme seeks to generate long term capital appreciation/income by investing in equity & equity related instruments of up to 30 companies. |
Launch Date | 12 Jul 2022 | 20 Aug 2004 |
Description
Launch Date